Close Menu

NEW YORK – NeuMoDx Molecular said on Friday that it received CE-IVD marking for its assay to detect and differentiate Trichomonas vaginalis and/or Mycoplasma genitalium in clinical urine samples.

The Ann Arbor, Michigan-based company has launched the assay, which is for use with NeuMoDx Molecular systems. The assay leverages nucleic acid amplification technology for the automated detection of T. vaginalis and M. genitalium simultaneously.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.